Neuroscience and Medicine

Neuroscience and Medicine

ISSN Print: 2158-2912
ISSN Online: 2158-2947
www.scirp.net/journal/nm
E-mail: [email protected]
Citations    
"5-HT4 Receptor Agonists for the Treatment of Alzheimer’s Dsease"
written by Ishtiyaque Ahmad, Ramakrishna Nirogi,
published by Neuroscience and Medicine, Vol.2 No.2, 2011
has been cited by the following article(s):
  • Google Scholar
  • CrossRef
[1] Understanding the Molecular Basis of 5-HT4 Receptor Partial Agonists through 3D-QSAR Studies
2021
[2] Modulation of the Serotonergic Receptosome in the Treatment of Anxiety and Depression: A Narrative Review of the Experimental Evidence
2021
[3] Small Molecule Drugs for Treatment of Alzheimer's Diseases Developed on the Basis of Mechanistic Understanding of the Serotonin Receptors 4 and 6
2021
[4] The bidirectional effect of prelimbic 5-hydroxytryptamine type-4 (5-HT4) receptors on ACPA-mediated aversive memory impairment in adult male Sprague-Dawley rats
2021
[5] Discovery and Preclinical Characterization of Usmarapride (SUVN-D4010): A Potent, Selective 5-HT4 Receptor Partial Agonist for the Treatment of Cognitive Deficits …
Journal of Medicinal …, 2021
[6] The bidirectional effect of prelimbic 5-hydroxytryptamine type-4 (5-HT4) receptors on ACPA-mediated aversive memory impairment in adult male Sprague …
Mahmoodabadi… - Iranian Journal of …, 2021
[7] Nouvelles formulations nanoparticulaires pour le repositionnement du tégasérod en vue du traitement de la maladie d'Alzheimer
2021
[8] Medicinal chemistry with pharmaceutical product development
2019
[9] A neuropharmacological study of 5-HT4 and 5-HT6 receptors and their relevance to Alzheimer's disease
2019
[10] Protein Function As Cell Surface And Nuclear Receptor In Human Diseases
2019
[11] Multi-Target-Directed Ligands Affecting Serotonergic Neurotransmission for Alzheimer's Disease Therapy: Advances in Chemical and Biological Research
Current Medicinal Chemistry, 2018
[12] Synthesis, Structure Activity Relationships and Preclinical evaluation of Heteroaromatic Amides and 1, 3, 4-Oxadiazole Derivatives as 5-HT4 Receptor Partial Agonists
Journal of Medicinal Chemistry, 2018
[13] Multi-targeting Strategies for Alzheimer's Disease Therapeutics: Pros and Cons
Current Topics in Medicinal Chemistry, 2017
[14] Receptor Targets in Alzheimer's Disease Drug Discovery
Drug Discovery Approaches for the Treatment of Neurodegenerative Disorders, 2017
[15] Recent progress in repositioning Alzheimer's disease drugs based on a multitarget strategy
2016
[16] Synthesis and SAR of Imidazo [1, 5-a] pyridine derivatives as 5-HT 4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's disease
European journal of medicinal chemistry, 2015
[17] Synthesis and SAR of Imidazo [1, 5-a] pyridine derivatives as 5-HT4 receptor partial agonists for the treatment of cognitive disorders associated with Alzheimer's …
European Journal of Medicinal Chemistry, 2015
[18] Practical synthesis of 5-amino-6-chlorochroman-8-carboxylic acid–a key intermediate for several potent 5-HT4 receptor agonists
Green Chemistry Letters and Reviews, 2014
[19] Practical synthesis of 5-amino-6-chlorochroman-8-carboxylic acid – a key intermediate for several potent 5-HT4 receptor agonists
Green Chemistry Letters and Reviews, 2014
[20] Novel Benzoisoxazole as Partial Agonist of the 5-HT4 Receptor: Patent Highlight
ACS Medicinal Chemistry Letters, 2012
[21] Novel Benzoisoxazole as Partial Agonist of the 5?HT4 Receptor
2012
[22] Novel Benzoisoxazole as Partial Agonist of the 5-HT4 Receptor
ACS Medicinal Chemistry Letters, 2012
SCIRP Newsletter
Copyright © 2006-2026 Scientific Research Publishing Inc. All Rights Reserved.
Top